Applied Molecular Transport EPS Ratio 2011-2026 | AMTI

EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.

The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares^[1]

EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.

A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.

EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.

Annual EPS Ratio Applied Molecular Transport

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-3.25	-2.67	-2.91	-3.81	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-2.67	-3.81	-3.16

Quarterly EPS Ratio Applied Molecular Transport

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-0.17	-0.44	-0.71	-	-0.65	-0.93	-1.1	-	-0.68	-0.62	-0.58	-	-0.48	-1.11	-2.06	-	-1.07	-0.99	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-0.17	-2.06	-0.828

References

Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.

EPS Ratio of other stocks in the Biotechnology industry

Issuer	EPS Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-15.4	-	2.43 %	$ 254 M	Germany
Amgen AMGN	14.3	$ 350.54	0.79 %	$ 189 B	USA
Amphastar Pharmaceuticals AMPH	2.1	$ 19.39	-0.56 %	$ 906 M	USA
Altimmune ALT	-1	$ 3.45	3.14 %	$ 304 M	USA
Autolus Therapeutics plc AUTL	-0.86	$ 1.4	1.82 %	$ 357 M	Britain
I-Mab IMAB	-7.66	-	-	$ 866 M	China
Genfit SA GNFT	1.51	-	2.54 %	$ 160 B	France
Aytu BioScience AYTU	-2.16	$ 2.62	0.21 %	$ 16.5 M	USA
Biophytis SA BPTS	-0.26	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	-8.28	$ 219.22	-1.2 %	$ 5 B	Danmark
Midatech Pharma plc MTP	-31	-	-18.52 %	$ 27.3 M	Britain
Applied Genetic Technologies Corporation AGTC	-0.36	-	-	$ 26.5 M	USA
Benitec Biopharma BNTC	-0.21	$ 11.01	0.27 %	$ 453 M	USA
ARCA biopharma ABIO	-3.87	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	-0.07	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-13.7	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-204	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	-1.77	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	-3.51	-	10.36 %	$ 9.8 M	USA
Compugen Ltd. CGEN	0.38	$ 2.12	1.44 %	$ 198 M	Israel
Acasti Pharma ACST	-0.79	-	4.01 %	$ 150 M	Canada
Coherus BioSciences CHRS	1.43	$ 1.58	3.95 %	$ 185 M	USA
Avenue Therapeutics ATXI	-15.8	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	-6.62	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-1.66	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-7.99	-	-9.65 %	$ 45.9 M	USA
Cellectis S.A. CLLS	-2.55	$ 3.39	1.5 %	$ 116 M	France
CollPlant Biotechnologies Ltd. CLGN	-1.45	$ 0.6	-1.79 %	$ 6.87 M	Israel
Ayala Pharmaceuticals AYLA	-2.46	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	2.46	$ 12.85	0.86 %	$ 774 M	USA
Atreca BCEL	-2.52	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	0.85	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	0.2	-	0.49 %	$ 251 B	Cayman-islands
CorMedix CRMD	2.25	$ 6.43	2.88 %	$ 463 K	USA
Cara Therapeutics CARA	-2.19	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-1.89	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	-2.08	-	-74.18 %	$ 955 K	USA
CytomX Therapeutics CTMX	-0.15	$ 4.41	-1.01 %	$ 608 M	USA
Checkpoint Therapeutics CKPT	-1.42	-	-	$ 169 M	USA
Clovis Oncology CLVS	-2.29	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	-24.9	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-2.21	-	-	$ 867 M	Germany
Denali Therapeutics DNLI	-2.57	$ 21.1	4.59 %	$ 3.47 B	USA
Dyadic International DYAI	-0.24	$ 0.9	-4.79 %	$ 25.9 M	USA
Akero Therapeutics AKRO	-3.75	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	-0.44	$ 4.29	1.06 %	$ 712 M	Canada